We make a complicated, hype-prone field easier to follow.

Our purpose

Hair-follicle regeneration sits between developmental biology, cell manufacturing, cosmetic medicine and consumer hope. We track the field with a simple objective: show what has been demonstrated, what is being tested and what remains a forecast.

Evidence ladder

1. Approved treatmentAuthorised by the relevant regulator for the stated use.
2. Controlled human evidenceResults from a registered comparative study with defined endpoints.
3. Early human evidenceSafety, feasibility or exploratory treatment data.
4. Preclinical evidenceLaboratory, organoid, animal or humanised-animal results.
5. Developer claimA company statement without sufficient public results for independent assessment.

Editorial standards

We prefer trial registries, regulator publications and peer-reviewed papers. Company materials are used as primary sources for what a developer says about its own program and are identified accordingly. We do not accept payment to change an evidence rating.

Launch articles are researched and drafted with AI assistance under human publisher oversight. Automation is used to monitor sources, not to invent evidence or mass-produce search pages.

Corrections and contact

Send corrections, source material or interview proposals to editor@haircloning.info. Material corrections will be noted with the date and reason.